Kemp has pioneered the use of computational systems biology models to understand and predict cellular behaviors in development, health, and disease, and provide the scientific community with a roadmap for new diagnostic and treatment pathways for a wide range of diseases. Her models have forced the field of molecular biology to develop new methods for measuring short-lived molecules and protein modifications, which she proposes are the unique “fingerprints” of cell communication, post-genetic variability, and cell stress responses that are responsible for biological variability.

Kemp’s models are the key to unlock the basis for (and opportunities of) personalized medicine and patient-specific therapies. Importantly, subsequent experiments by colleagues in the field have validated her paradigm-shifting theories. Her innovative scholarship has been recognized by many awards: NIH New Innovator, the CSF2 Prize for Innovative Measurement Methods, and the Georgia Cancer Coalition Distinguished Scholar award.